ID: ALA3144029

Max Phase: Preclinical

Molecular Formula: C20H27N7O13P2S

Molecular Weight: 667.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=O)c1csc([C@@H]2O[C@H](COP(=O)(O)CP(=O)(O)OC[C@@H]3O[C@H](n4cnc5c(N)ncnc54)[C@@H](O)[C@H]3O)[C@@H](O)[C@H]2O)n1

Standard InChI:  InChI=1S/C20H27N7O13P2S/c21-16-10-18(24-4-23-16)27(5-25-10)20-14(31)12(29)9(40-20)2-38-42(35,36)6-41(33,34)37-1-8-11(28)13(30)15(39-8)19-26-7(3-43-19)17(22)32/h3-5,8-9,11-15,20,28-31H,1-2,6H2,(H2,22,32)(H,33,34)(H,35,36)(H2,21,23,24)/t8-,9+,11-,12+,13-,14+,15-,20+/m1/s1

Standard InChI Key:  CRWWKLKZKYLFQV-VSKCBFOOSA-N

Associated Targets(Human)

Inosine-5'-monophosphate dehydrogenase 1 221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Inosine-5'-monophosphate dehydrogenase 2 1326 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 20296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Inosine-5'-monophosphate dehydrogenase 2 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 667.49Molecular Weight (Monoisotopic): 667.0863AlogP: -2.19#Rotatable Bonds: 11
Polar Surface Area: 318.04Molecular Species: ACIDHBA: 18HBD: 8
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.81CX Basic pKa: 4.92CX LogP: -7.39CX LogD: -9.23
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.10Np Likeness Score: 0.57

References

1. Zatorski A, Goldstein BM, Colby TD, Jones JP, Pankiewicz KW..  (1995)  Potent inhibitors of human inosine monophosphate dehydrogenase type II. Fluorine-substituted analogues of thiazole-4-carboxamide adenine dinucleotide.,  38  (7): [PMID:7707313] [10.1021/jm00007a007]
2. Pankiewicz KW, Lesiak K, Zatorski A, Goldstein BM, Carr SF, Sochacki M, Majumdar A, Seidman M, Watanabe KA..  (1997)  The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).,  40  (8): [PMID:9111303] [10.1021/jm960641y]
3. Marquez VE, Tseng CK, Gebeyehu G, Cooney DA, Ahluwalia GS, Kelley JA, Dalal M, Fuller RW, Wilson YA, Johns DG..  (1986)  Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.,  29  (9): [PMID:2875185] [10.1021/jm00159a027]
4. Lesiak K, Watanabe KA, Majumdar A, Seidman M, Vanderveen K, Goldstein BM, Pankiewicz KW..  (1997)  Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.,  40  (16): [PMID:9258359] [10.1021/jm970247f]
5. Pankiewicz KW, Lesiak-Watanabe KB, Watanabe KA, Patterson SE, Jayaram HN, Yalowitz JA, Miller MD, Seidman M, Majumdar A, Prehna G, Goldstein BM..  (2002)  Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.,  45  (3): [PMID:11806722] [10.1021/jm0104116]

Source